Cite
HARVARD Citation
Edenfield, W. et al. (2021). A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers. Oncologist. pp. e1499-e1507. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Edenfield, W. et al. (2021). A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers. Oncologist. pp. e1499-e1507. [Online].